Advertisement
Home »

PROFILE Trial: Top-Down Treatment Strategy Benefits Patients With Early Crohn’s Disease

Mar 01, 2024

REFERENCES & ADDITIONAL READING

Biasci D, et al. A blood-based prognostic biomarker in IBD [published correction appears in Gut. 2019 Oct;68(10):1909-1912]. Gut. 2019;68(8):1386-1395. doi:10.1136/gutjnl-2019-318343

Noor N, et al. PROFILE trial: a biomarker-stratified, clinical trial of treatment strategies in patients with newly diagnosed Crohn’s disease. OP01, 19th Congress of ECCO, February 21–24, 2024, Stockholm, Sweden.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement